Author
Listed:
- John T. Powers
(Boston Children’s Hospital)
- Kaloyan M. Tsanov
(Boston Children’s Hospital)
- Daniel S. Pearson
(Boston Children’s Hospital)
- Frederik Roels
(University Hospital Köln)
- Catherine S. Spina
(Wyss Institute for Biologically Inspired Engineering)
- Richard Ebright
(Boston Children’s Hospital)
- Marc Seligson
(Boston Children’s Hospital)
- Yvanka de Soysa
(Boston Children’s Hospital)
- Patrick Cahan
(Boston Children’s Hospital)
- Jessica Theißen
(University Hospital Köln)
- Ho-Chou Tu
(Boston Children’s Hospital)
- Areum Han
(Boston Children’s Hospital)
- Kyle C. Kurek
(Boston Children’s Hospital)
- Grace S. LaPier
(Boston Children’s Hospital)
- Jihan K. Osborne
(Boston Children’s Hospital)
- Samantha J. Ross
(Boston Children’s Hospital)
- Marcella Cesana
(Boston Children’s Hospital)
- James J. Collins
(Wyss Institute for Biologically Inspired Engineering
Massachusetts Institute of Technology, Broad Institute of MIT and Harvard)
- Frank Berthold
(University Hospital Köln)
- George Q. Daley
(Boston Children’s Hospital
Stem Cell Transplantation Program, Dana Farber Cancer Institute & Boston Children’s Hospital
Harvard Medical School
Harvard Stem Cell Institute)
Abstract
Poor prognosis in neuroblastoma is associated with genetic amplification of MYCN. MYCN is itself a target of let-7, a tumour suppressor family of microRNAs implicated in numerous cancers. LIN28B, an inhibitor of let-7 biogenesis, is overexpressed in neuroblastoma and has been reported to regulate MYCN. Here we show, however, that LIN28B is dispensable in MYCN-amplified neuroblastoma cell lines, despite de-repression of let-7. We further demonstrate that MYCN messenger RNA levels in amplified disease are exceptionally high and sufficient to sponge let-7, which reconciles the dispensability of LIN28B. We found that genetic loss of let-7 is common in neuroblastoma, inversely associated with MYCN amplification, and independently associated with poor outcomes, providing a rationale for chromosomal loss patterns in neuroblastoma. We propose that let-7 disruption by LIN28B, MYCN sponging, or genetic loss is a unifying mechanism of neuroblastoma development with broad implications for cancer pathogenesis.
Suggested Citation
John T. Powers & Kaloyan M. Tsanov & Daniel S. Pearson & Frederik Roels & Catherine S. Spina & Richard Ebright & Marc Seligson & Yvanka de Soysa & Patrick Cahan & Jessica Theißen & Ho-Chou Tu & Areum , 2016.
"Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma,"
Nature, Nature, vol. 535(7611), pages 246-251, July.
Handle:
RePEc:nat:nature:v:535:y:2016:i:7611:d:10.1038_nature18632
DOI: 10.1038/nature18632
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:535:y:2016:i:7611:d:10.1038_nature18632. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.